Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee

Summary

This is a phase III, multicentre, randomized, double blind, parallel-group, pilot study designed to compare a long term (12 weeks) versus a short term (2 weeks) treatment with celecoxib 200 mg/die in treatment and prevention of new flare in patients with osteoarthritis of the knee.

Timeline

Start

2002-11

Primary completion

2006-03

Completion

2006-03

Drugs

Indications